Physician profile
Christopher M Senger
NPI 1669662169
$2,415.80
in general payments reported to CMS, 2019-2025
7 companies · $1,007 in 2025
The $1,007 reported for 2025 was more than what 84% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.68 · 2020: $47.85 · 2021: $218 · 2022: $129 · 2023: $96.02 · 2024: $870 · 2025: $1,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,470 · Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,470.20 |
| Food and Beverage | $502.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,875.33 | 2023-2025 | |
| Allergan, INC. | $300.34 | 2019-2022 | |
| Revance Therapeutics, INC. | $83.33 | 2025 | Daxxify |
| Merz North America, INC. | $80.31 | 2020-2022 | |
| Galderma Laboratories, L.P. | $40.63 | 2019-2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.98 | 2021 | |
| Acella Pharmaceuticals, LLC | $13.88 | 2024 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Senger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.